By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Tocagen Inc. 

3030 Bunker Hill Street
Suite 230
San Diego  California  92109  U.S.A.
Phone: 858-412-8400 Fax: 858-412-8499


Company News
Tocagen Inc. Appoints Paul Schimmel, Ph.D., To The Board Of Directors 2/25/2015 7:28:09 AM
Tocagen Inc. Appoints Franklin M. Berger, CFA, To The Board Of Directors 12/2/2014 12:39:40 PM
Interim Data Show Increased Median Overall Survival Of Recurrent Brain Cancer Patients Treated With Tocagen Inc.'s Toca 511 & Toca FC, Compared To Published Benchmarks 11/18/2014 1:25:58 PM
Tocagen Inc. Appoints Faheem Hasnain As Chairman Of The Board Of Directors 11/14/2014 8:25:30 AM
Tocagen Inc. To Present Toca 511 Data At The 19th Annual Scientific Meeting And Education Day Of The Society For Neuro-Oncology 11/11/2014 8:32:15 AM
Tocagen Inc. Expands Clinical Development Team 8/26/2014 9:09:57 AM
Data for Tocagen Inc.'s Toca 511 Presented At The American Society Of Gene And Cell Therapy Annual Meeting 5/22/2014 7:11:23 AM
Tocagen Inc. Names Jamey Skillings, M.D., Chief Medical Officer 3/25/2014 7:07:00 AM
Data Presented At Society For Neuro-Oncology Annual Meeting Demonstrate Tocagen Inc.'s Toca 511 Gene Therapy With Toca FC Was Well Tolerated And Showed Antitumor Activity In Patients With High Grade Glioma 11/26/2013 7:26:57 AM
Voices Against Brain Cancer Awards Grant to Tocagen Inc. to Support Investigation of Toca 511 & Toca FC in Patients with Recurrent Brain Cancer 6/20/2013 8:57:43 AM